전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved60 programs
CGTLimited DatastaleBeijing GoBroad HospitalPhase 2

CD19-BCMA CAR-T cells infusion (CD19-BCMA CAR-T cells infusion)

Refractory Lupus Nephritis; Systemic Sclerosis · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleUnion Hospital, Tongji Medical …Phase 1

CD19/BCMA CAR-T cell therapy (CD19/BCMA CAR-T cell therapy)

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShanghai AbelZeta Ltd.Phase 1

CD20-directed CAR-T cells with CliniMACS Prodigy® system (CD20-directed CAR-T cells with CliniMACS Prodigy® system)

B Cell Lymphoma · CD20

#CD20#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
AntibodyLimited DatastaleTokyo UniversityPhase 3

Double-Blind Rituximab (Double-Blind Rituximab)

Scleroderma, Systemic; Skin Sclerosis · Scleroderma, Systemic

#SclerodermaSystemic#Antibody#Phase3#monoclonal-antibody#Scleroderma+3
Trials 1Status Active
CGTLimited DatastaleSeattle Children's HospitalPhase 1

EGFR806-specific chimeric antigen receptor (CAR, EGFR806-specific chimeric antigen receptor, EGFR806-specific chimeric antigen receptor (CAR) T cell)

Central Nervous System Tumor, Pediatric; Glioma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Active
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 1

Engineering of chimeric antigen receptors targeting CD19 in allogeneic T cells (Engineering of chimeric antigen receptors targeting CD19 in allogeneic T cells)

Difficult to Treat Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix (Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix)

Primary Central Nervous System Lymphoma · Primary Central Nervous System Lymphoma

#PrimaryCentralNervousSystemLymph#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Recruiting
CGTLimited DatastaleSeattle Children's HospitalPhase 1

HER2-specific chimeric antigen receptor (CAR, HER2-specific chimeric antigen receptor, HER2-specific chimeric antigen receptor (CAR) T cell)

Central Nervous System Tumor, Pediatric; Glioma · HER2

#HER2#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleSeattle Children's HospitalPhase 1

SCRI-CAR19v3 (SCRI-CAR19v3)

Systemic Lupus Erythematosus · Systemic Lupus Erythematosus

#SystemicLupusErythematosus#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleSeattle Children's HospitalPhase 1

SCRI-CARB7H3 (SCRI-CARB7H3, SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel)

Central Nervous System Tumor; Diffuse Intrinsic Pontine Glioma · Central Nervous System Tumor

#CentralNervousSystemTumor#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastalePeking UniversityPhase 1

ScTIL injection and B lymphocytes adjuvant (ScTIL injection and B lymphocytes adjuvant)

Digestive System Malignant Solid Tumors · Digestive System Malignant Solid Tumors

#DigestiveSystemMalignantSolidTum#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
AntibodyLimited DatastaleSanofiPreclinical

Systemic dupilumab (Systemic dupilumab)

Dermatitis, Atopic · Dermatitis, Atopic

#DermatitisAtopic#Antibody#Preclinical#monoclonal-antibody#Dermatitis+2
Trials 1Status Active
AntibodyLimited DatastaleUMC UtrechtPhase 2

FTD-TPI and bevacizumab (Systemic treatment, Systemic treatment (FTD-TPI and bevacizumab))

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#monoclonal-antibody#UMC
Trials 1Status Recruiting
AntibodyLimited DatastaleChinese SLE Treatment And Resea…Approved

Telitacicept (Telitacicept)

ANCA Associated Vasculitis · Systemic Lupus Erythematosus (SLE)

#SystemicLupusErythematosusSLE#Antibody#Approved#monoclonal-antibody#ANCAAssociatedVasculitis+1
Trials 1Status Recruiting
CGTLimited DatastaleThe Children's Hospital of Zhej…Phase 1

UCAR T-cell (UCAR T-cell)

Autoimmune Diseases; Systemic Lupus Erthematosus (SLE) · Autoimmune Diseases

#AutoimmuneDiseases#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleChengdu Ucello Biotechnology Co…Phase 1

allogeneic umbilical cord blood-derived CAR-T targeting CD19 and BCMA (allogeneic umbilical cord blood-derived CAR-T targeting CD19 and BCMA)

SLE - Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleThe Children's Hospital of Zhej…Phase 1

anti-BCMA/CD70-CAR-T cells (anti-BCMA/CD70-CAR-T cells)

CAR T Cell Therapy; Systemic Lupus Erythematosus · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleNational University Health Syst…Phase 1

anti-CD19 redirected NK cells (anti-CD19 redirected NK cells)

B-cell Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleGracell Biotechnologies (Shangh…Preclinical

CHT105 (anti-CD19/70 CAR T cells, anti-CD19/70 CAR T cells (CHT105))

Systemic Lupus Erythematosus; Lupus Nephritis · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleBeijing GoBroad HospitalPhase 2

umbilical cord blood CD19-BCMA CAR-T cells infusion (umbilical cord blood CD19-BCMA CAR-T cells infusion)

Refractory Lupus Nephritis; Systemic Sclerosis · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting

3 / 3 pages

← PreviousNext →